138 related articles for article (PubMed ID: 37541806)
1. ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia.
Lipreri da Silva JC; Coelho-Silva JL; Vicari HP; Lima K; Rego EM; Traina F; Machado-Neto JA
Hematol Transfus Cell Ther; 2024; 46(1):101-105. PubMed ID: 37541806
[No Abstract] [Full Text] [Related]
2. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
[TBL] [Abstract][Full Text] [Related]
3. The impact of BCR-ABL1 transcript type on tyrosine kinase inhibitor responses and outcomes in patients with chronic myeloid leukemia.
Ercaliskan A; Eskazan AE
Cancer; 2018 Oct; 124(19):3806-3818. PubMed ID: 29694669
[TBL] [Abstract][Full Text] [Related]
4. ARHGAP6 Suppresses Breast Cancer Tumor Growth by Promoting Ferroptosis via RhoA-ROCK1-p38 MAPK Signaling.
Chen X; Zhu J; Li X; Chen J; Zhou Z; Fan X; Liang R; Liu H; Zhu D
Front Biosci (Landmark Ed); 2024 Jan; 29(1):6. PubMed ID: 38287795
[TBL] [Abstract][Full Text] [Related]
5. ARHGAP6 inhibits bladder cancer cell viability, migration, and invasion via β-catenin signaling and enhances mitomycin C sensitivity.
Chen W; Tan M; Yu C; Liao G; Kong D; Bai J; Yang B; Gong H
Hum Cell; 2023 Mar; 36(2):786-797. PubMed ID: 36715867
[TBL] [Abstract][Full Text] [Related]
6. Regulation of phospholipase C-delta1 by ARGHAP6, a GTPase-activating protein for RhoA: possible role for enhanced activity of phospholipase C in hypertension.
Ochocka AM; Grden M; Sakowicz-Burkiewicz M; Szutowicz A; Pawelczyk T
Int J Biochem Cell Biol; 2008; 40(10):2264-73. PubMed ID: 18434237
[TBL] [Abstract][Full Text] [Related]
7. ARHGAP6 Promotes Apoptosis and Inhibits Glycolysis in Lung Adenocarcinoma Through STAT3 Signaling Pathway.
Li P; Lv H; Xu M; Zang B; Ma Y
Cancer Manag Res; 2020; 12():9665-9678. PubMed ID: 33116826
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of dynamic monitoring of RUNX1-RUNX1T1 transcript in pediatric acute myeloid leukemia].
Gao HT; Zhang Y; Sun K; Guo JM; Chen YQ; Chen XL; Shi J; Niu XN; Wang F; Huo L
Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):210-215. PubMed ID: 28395444
[No Abstract] [Full Text] [Related]
9. Genetic screening in C. elegans identifies rho-GTPase activating protein 6 as novel HERG regulator.
Potet F; Petersen CI; Boutaud O; Shuai W; Stepanovic SZ; Balser JR; Kupershmidt S
J Mol Cell Cardiol; 2009 Feb; 46(2):257-67. PubMed ID: 19038263
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of ARHGAP6, a novel GTPase-activating protein for RhoA.
Prakash SK; Paylor R; Jenna S; Lamarche-Vane N; Armstrong DL; Xu B; Mancini MA; Zoghbi HY
Hum Mol Genet; 2000 Mar; 9(4):477-88. PubMed ID: 10699171
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of Arhgap6 on cervical carcinoma cells.
Li J; Liu Y; Yin Y
Tumour Biol; 2016 Feb; 37(2):1411-25. PubMed ID: 26628301
[TBL] [Abstract][Full Text] [Related]
12. MiR-96-5p is an oncogene in lung adenocarcinoma and facilitates tumor progression through ARHGAP6 downregulation.
Liu Z; Cui Y; Wang S; Wu C; Mei F; Han E; Hu Z; Zhou B
J Appl Genet; 2021 Dec; 62(4):631-638. PubMed ID: 34338998
[TBL] [Abstract][Full Text] [Related]
13. Amelogenesis imperfecta in two families with defined AMELX deletions in ARHGAP6.
Hu JC; Chan HC; Simmer SG; Seymen F; Richardson AS; Hu Y; Milkovich RN; Estrella NM; Yildirim M; Bayram M; Chen CF; Simmer JP
PLoS One; 2012; 7(12):e52052. PubMed ID: 23251683
[TBL] [Abstract][Full Text] [Related]
14. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.
Ponciano-Gómez A; Martínez-Tovar A; Vela-Ojeda J; Olarte-Carrillo I; Centeno-Cruz F; Garrido E
Tumour Biol; 2017 Oct; 39(10):1010428317732181. PubMed ID: 28992762
[TBL] [Abstract][Full Text] [Related]
15. Expression in Escherichia coli of human ARHGAP6 gene and purification of His-tagged recombinant protein.
Ochocka AM; Czyzewska M; Pawełczyk T
Acta Biochim Pol; 2003; 50(1):239-47. PubMed ID: 12673365
[TBL] [Abstract][Full Text] [Related]
16. High transcript level of FLT3 associated with high risk of relapse in pediatric acute myeloid leukemia.
Kang HJ; Lee JW; Kho SH; Kim MJ; Seo YJ; Kim H; Shin HY; Ahn HS
J Korean Med Sci; 2010 Jun; 25(6):841-5. PubMed ID: 20514303
[TBL] [Abstract][Full Text] [Related]
17. PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia.
Lima K; Coelho-Silva JL; Kinker GS; Pereira-Martins DA; Traina F; Fernandes PACM; Markus RP; Lucena-Araujo AR; Machado-Neto JA
Cancer Genet; 2019 Apr; 233-234():56-66. PubMed ID: 31109595
[TBL] [Abstract][Full Text] [Related]
18. Exosomal miR‑152‑5p/ARHGAP6/ROCK axis regulates apoptosis and fibrosis in cardiomyocytes.
Chen S; Huang Y; Liu R; Lin Z; Huang B; Ai W; He J; Gao Y; Xie P
Exp Ther Med; 2023 Apr; 25(4):165. PubMed ID: 36936709
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel variant BCR-ABL1 fusion transcript in a patient with chronic myeloid leukemia: Implications for molecular monitoring.
Crampe M; Haslam K; Kelly J; Conneally E; Langabeer SE
Hematol Oncol Stem Cell Ther; 2017 Jun; 10(2):85-88. PubMed ID: 27013275
[TBL] [Abstract][Full Text] [Related]
20. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia.
Prejzner W
Med Sci Monit; 2002 May; 8(5):BR193-7. PubMed ID: 12011769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
